Last 12 months
Inside the activity.
0 purchase rows · 46 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 7 |
| Dec 2025 | 0 | 9 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 15 |
| Aug 2026 | 0 | 5 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2016 Filed Oct 4, 2016 20:39 UTC |
BIENAIME JEAN JACQUESDirector
|
GrantCommon Stock | 153 | $94.29 | $14,426.37 |
DisclosureSEC source: 0001209191-16-144309 · doc4.xml · nonDerivative · entry 1 BIENAIME JEAN JACQUES · CIK 0001221590 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 925 F1 · security: Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1. Restricted shares are fully vested. Read SEC document |
| September 23, 2016 Filed Sep 26, 2016 20:34 UTC |
SWAIN PAULA JEVP, Human Resources
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $14.72 | $0.00 |
DisclosureSEC source: 0001209191-16-142798 · doc4.xml · derivative · entry 3 SWAIN PAULA J · CIK 0001236934 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,317 Underlying: Common Stock · 20,000 shares Expires 2018-01-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Beginning January 25, 2011, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years. Read SEC document |
| September 23, 2016 Filed Sep 26, 2016 20:34 UTC |
SWAIN PAULA JEVP, Human Resources
|
SaleCommon Stock | 20,000 | $90.00 | $1,800,000.00 |
DisclosureSEC source: 0001209191-16-142798 · doc4.xml · nonDerivative · entry 2 SWAIN PAULA J · CIK 0001236934 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,248 F1 · price: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: Includes an aggregate of 11,187 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. Read SEC document |
| September 23, 2016 Filed Sep 26, 2016 20:34 UTC |
SWAIN PAULA JEVP, Human Resources
|
Exercise / conversionCommon Stock | 20,000 | $14.72 | $294,400.00 |
DisclosureSEC source: 0001209191-16-142798 · doc4.xml · nonDerivative · entry 1 SWAIN PAULA J · CIK 0001236934 · EVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,248 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 24, 2016 Filed Feb 28, 2017 21:56 UTC |
Huber Reid MEVP, Chief Scientific Officer
|
Tax withholdingCommon Stock | 1,090 | $121.95 | $132,925.50 |
DisclosureSEC source: 0001209191-17-015338 · doc4.xml · nonDerivative · entry 2 Huber Reid M · CIK 0001607052 · EVP, Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,270 F3 · shares: Represents shares withheld to satisfy tax withholding obligations with respect to vested performance shares. F2 · balance_after: Includes an aggregate of 27,496 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. Read SEC document |
| February 14, 2016 Filed Feb 28, 2017 21:56 UTC |
Huber Reid MEVP, Chief Scientific Officer
|
GrantCommon Stock | 3,098 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-015338 · doc4.xml · nonDerivative · entry 1 Huber Reid M · CIK 0001607052 · EVP, Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,360 F1 · shares: Represents shares acquired upon vesting of performance shares. Each performance share represented the right to receive one or more shares of common stock based on, and subject to, the achievement of certain clinical and revenue milestones as set forth in the Performance Share Award Agreement. The number of shares of common stock that the Reporting Person was entitled to receive ranged from 0% to 125% of the number of performance shares awarded. Performance share milestones were achieved at the 100% level. F2 · balance_after: Includes an aggregate of 27,496 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.